NCT04482933 2026-02-10
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Pediatric Brain Tumor Consortium
Phase 2 Withdrawn
Clinical Trials
24 trialsNCT07011849 2025-08-13
Study of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain Metastases
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT05620914 2025-06-15
PARAMETer
Duke University
Phase 2 Withdrawn
NCT05840770 2025-05-26
Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer
City of Hope Medical Center
Phase 2 Withdrawn
NCT03925675 2024-09-03
18F-Fluciclovine PET and Multiparametric MR Imaging
Loma Linda University
Phase 2 Withdrawn
NCT05999357 2024-05-29
STRIDER
Maastricht University Medical Center
Phase 2 Withdrawn
NCT04427228 2023-08-28
MIGRAINE
University of Chicago
Phase 2 Withdrawn
NCT05255666 2023-07-11
Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)
Washington University School of Medicine
Phase 2 Withdrawn
NCT04650490 2023-03-02
STICk-IM-NSCLC
Duke University
Phase 2 Withdrawn
NCT04856475 2022-03-02
NeraBrain
Jules Bordet Institute
Phase 2 Withdrawn
NCT03868423 2022-02-18
Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers
Ohio State University Comprehensive Cancer Center
Phase 2 Withdrawn
NCT03234309 2021-11-10
Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors
OHSU Knight Cancer Institute
Phase 2 Withdrawn
NCT03637868 2020-05-06
ERIBRAIN
Institut Paoli-Calmettes
Phase 2 Withdrawn
NCT02014545 2018-07-05
Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer
Wake Forest University Health Sciences
Phase 2 Withdrawn
NCT02348255 2018-01-09
NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
University of California, Davis
Phase 2 Withdrawn
NCT01736800 2017-09-19
Phase II Trial of Chemotherapy With Temodar With Topotecan for CNS Metastasis of Solid Tumors
The Methodist Hospital Research Institute
Phase 2 Withdrawn
NCT02425072 2017-08-10
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
University of Kentucky
Phase 2 Withdrawn
NCT01413438 2017-07-02
Bevacizumab With or Without Surgery for Adult Glioblastomas
National Institutes of Health Clinical Center (CC)
Phase 2 Withdrawn
NCT01445691 2016-05-17
More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
Icahn School of Medicine at Mount Sinai
Phase 2 Withdrawn
NCT02599090 2015-11-06
Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT01913067 2014-07-24
CRANIAL
Jules Bordet Institute
Phase 2 Withdrawn
NCT01169116 2014-02-04
Exclusive Hypofractionated Stereotactic Radiotherapy in Non-resectable Single Brain Metastasis
Barretos Cancer Hospital
Phase 2 Withdrawn
NCT00385398 2013-09-02
QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC
Rutgers, The State University of New Jersey
Phase 2 Withdrawn
NCT00797940 2012-12-03
CLARITY-1
Protox Inc.
Phase 2 Withdrawn